Catoni, C.; Poggiana, C.; Facchinetti, A.; Pigozzo, J.; Piccin, L.; Chiarion-Sileni, V.; Rosato, A.; Minervini, G.; Scaini, M.C.
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach. Cancers 2022, 14, 4153.
https://doi.org/10.3390/cancers14174153
AMA Style
Catoni C, Poggiana C, Facchinetti A, Pigozzo J, Piccin L, Chiarion-Sileni V, Rosato A, Minervini G, Scaini MC.
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach. Cancers. 2022; 14(17):4153.
https://doi.org/10.3390/cancers14174153
Chicago/Turabian Style
Catoni, Cristina, Cristina Poggiana, Antonella Facchinetti, Jacopo Pigozzo, Luisa Piccin, Vanna Chiarion-Sileni, Antonio Rosato, Giovanni Minervini, and Maria Chiara Scaini.
2022. "Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach" Cancers 14, no. 17: 4153.
https://doi.org/10.3390/cancers14174153
APA Style
Catoni, C., Poggiana, C., Facchinetti, A., Pigozzo, J., Piccin, L., Chiarion-Sileni, V., Rosato, A., Minervini, G., & Scaini, M. C.
(2022). Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach. Cancers, 14(17), 4153.
https://doi.org/10.3390/cancers14174153
